The naturally occurring polyamines play an essential role in cell growth and proliferation. The levels of polyamines have been shown to increase in rapidly proliferating cancer cells. Therefore, compounds that inhibit enzymes in polyamine biosynthetic pathway may have therapeutic potential. Compounds capable of providing both in vitro and in vivo inhibition of almost all enzymes in the polyamine biosynthetic pathway are known. An exception is the lack of an agent that inhibits spermidine/spermine N 1 -acetyltransferase (SSAT), the rate-limiting enzyme in the catabolism of polyamines. The design, synthesis and characterization of five new polyamine analogues as potential inhibitors of SSAT are presented. Three compounds, N 1 -[3-(propenamido) propyl]-1,4-diaminobutane dihydrochloride 5 , N 1 -[3-(maleimido)propyl]-1,4-diamino-butane dihydrochloride 7 and N 1 -[3-(2-bromoacetamido)propyl]-1,4-diaminobutane dihydrochloride 9 , were designed as active-site-directed affinity label inhibitors. Two compounds, N-[N-(5-acetamido-2-hydroxypentyl-3-aminopropyl)]-1,4-diaminobutane trihydrochloride 12 and N-[3-(2-hydroxyethylamino)propyl]-1,4-diaminobutane trihydrochloride 14 , were designed as transition state-like analogue inhibitors. These compounds were synthesized using one key intermediate, N-(3-aminopropyl)-N,N ′ -bis-(tert-butoxycarbonyl)-1,4-diaminobutane 3 . Three of these synthesized compounds, 5 , 7 and 12 were evaluated for their ability to inhibit SSAT. The enzyme used was a crude extract of human large cell undifferentiated lung carcinoma cell line NCI H157 cells. These synthetic analogues when tested against the crude enzyme extract at concentrations of 0.05, 0.1, 1 and 5 μM appeared to show no effects on the activity of SSAT.

The mammalian polyamine transport system (PTS) has been of interest due to its roles in cancer and maintaining cellular homeostasis. Polyamines are essential growth factors which are tightly controlled via a balance of biosynthesis, metabolism, import, and export. This work focused on the development and biological testing of polyamine transport probes to help understand the molecular requirements of the PTS. This was mediated through the use of a CHO (PTS active) and CHO-MG* (PTS deficient) screen, where compounds demonstrating high toxicity in CHO and low toxicity in CHO-MG* were considered PTS selective. The first chapter focused on the development of polyamine-based drugs which are both metabolically stable to polyamine oxidase (PAO) activity and are hyperselective for targeting the PTS. This approach was optimized by combining a di-substituted aryl design with terminal N-methylation of the appended polyamine chains to generate a new class of superior PTS agonists. The metabolic stability of these compounds was demonstrated in CHO and CHO-MG* in the presence and absence of a known PAO inhibitor, aminoguanidine (AG). Highly PTS selective compounds were then tested in the NCI-60 cell line screen to demonstrate the effectiveness of polyamine-based drugs in cancer therapy. During this screen, the MALME-3M (human melanoma) cell line was identified as being very sensitive to these PTS targeting drugs. Further studies using MALME-3M and its normal counterpart, MALME-3, showed excellent targeting of the cancer line over MALME-3. For example, The MeN44Nap44NMe compound showed 59-fold higher toxicity in MALME-3M over MALME-3. The second chapter focused on the development of potential polyamine transport inhibitors (PTIs) for use in combination therapy with ?-difluoromethylornithine (DFMO). This therapy is predicated upon reducing sustained polyamine depletion within cells by inhibiting both polyamine biosynthesis with DFMO and polyamine transport with the PTI ligand. Potential PTIs were identified by blocking the uptake of spermidine in DFMO-treated CHO and L3.6pl cells. Previous work has identified a tri-substituted polyamine-based design as an effective PTI. Low toxicity and a low Ki value in a L1210 screen were good predictors for PTI efficacy. The structural requirements for a potent PTI were explored by modulating the toxicity through the introduction of amide bonds, and also by determining the number and orientation of the polyamine messages (appended to an aryl core) required for efficient inhibition of polyamine uptake. These experiments showed that a tri-substituted design and a triamine message (homospermidine) appended was optimal for PTI potency. The final chapter focused on the development of Dihydromotuporamine C derivatives as non-toxic anti-metastatic agents. Dihydromotuporamine C demonstrated good anti-invasive properties with tumor cells. Derivatives were made in an effort to reduce the cytotoxicity of the parent and improve the anti-migration potency. The motuporamine derivatives all have a polyamine message (norspermidine or homospermidine) appended to make a macrocycle core, making them prime targets to evaluate as potential PTS ligands in the CHO and CHO-MG* screen. Each compound was also tested in the highly metastatic pancreatic cancer cell line L3.6pl to determine both its IC50 value and maximum tolerated dose (MTD). The anti-migration assay was performed at the lowest MTD obtained (0.6 [micro]M) in order to compare the series at the same non-toxic dose. The results suggested that as the N1-amine center was moved further from the macrocyclic ring, an increased ability to inhibit cell migration and reduced toxicity was observed. These collective findings provide new tools for cell biologists to modulate and target polyamine transport in mammalian cells. Future applications of these technologies include new cancer therapies which are cell-selective and inhibit the spread of tumors.

No description available.

No description available.

No description available.

The N-methyl-D-aspartate (NMDA) receptors are highly regulated ligand-gated ion channels, which are affected by many substrates. Overactivation of the NMDA receptor can lead to hyperexcitability and a number of neurotoxic effects and neurological diseases. Agmatine has been demonstrated to act allosterically as an inhibitory modulator at the polyamine recognition sites of the NMDA receptor complex. The present study synthesized and evaluated a library of agmatine analogs for their ability to displace tritiated MK-801 from NMDARs in P2 membrane preparations from rat brains at ligand concentrations of 1 mM and 50 uM. A full dose-response curve was generated for the most active compounds, in the presence and absence of a pathological level of spermidine (100 uM). A forty-five member subset of arylidenamino-guanidino compounds was synthesized and all were demonstrated to be NMDA receptor inhibitory modulators in the above assay. Three of these compounds generated biphasic curves, indicating activity at two binding sites: the postulated high-affinity agmatine binding site, and a low-affinity site (perhaps the channel itself). (4-Chlorobenzylidenamino)-guanidine hydrochloride demonstrated an IC50 of 3.6 uM at the former site and 124.5 uM at the latter. Several computer models were generated to direct further synthesis. Based on the structure-activity relationship of the arylidenamino-guanidino compounds, a pharmacophore model of the agmatine binding site of the NMDAR was proposed.

Die heterotetramere Proteinkinase CK2 nimmt aufgrund der großen Anzahl und Diversität ihrer Substrate, sowie aufgrund ihrer Eigenschaft Signalwege miteinander zu vernetzen eine Sonderstellung innerhalb der Kinasen ein. CK2 beeinflusst Proliferation, Differenzierung und Apoptose, Prozesse an denen auch Polyamine und der MAPK-Signalweg beteiligt sind. Eine vor kurzem durchgeführte Arbeit beschreibt die Bindung von CK2 an das Gerüstprotein KSR und die Verstärkung des MAPK-Signalwegs durch Phosphorylierung von Raf-Proteinen in Vertebraten. In dieser Arbeit konnte gezeigt werden, dass CK2 auch in Drosophila mit KSR interagiert und das einzige in Drosophila vorhandene Raf-Potein (DRaf) in vitro phosphoryliert. Im Gegensatz zur Phosphorylierung der humanen B-Raf und C-Raf Proteine an Serin 446 bzw. Serin 338 innerhalb der „negative charge regulatory region“ (N-Region), führten Kinasereaktionen und Massenspektrometrische Untersuchungen zur Identifizierung von Serin 11 als CK2 Phosphorylierungsstelle in DRaf, während ein zu Serin 446 in B-Raf äquivalentes Serin in der N-Region in Drosophila nicht durch CK2 phosphoryliert wird. Durch Überexpression von DRaf sowie von zwei DRaf-Varianten bei denen Serin 11 durch Alanin oder Aspartat substituiert wurde (DRafS11A und DRafS11D) konnte in Zellkulturexperimenten gezeigt werden, dass die Ladung an der Aminosäureposition 11 die Funktion von DRaf beeinflusst, wobei eine negative Ladung an dieser Stelle zur Phosphorylierung und Aktivierung der Effektorkinase Erk führt. Die Phosphorylierung durch CK2 ist unabhängig von regulatorischen Botenstoffen ("second messengers"), wird aber durch Bindung von Polyaminen moduliert. Intrazelluläre Polyamine entstammen zum grossen Teil dem zellulären Aminosäurekatabolismus und beeinflussen die Phosphorylierung von DRaf durch CK2 in vitro, wobei Spermin ein effizienter Inhibitor der Reaktion ist, während die Effekte von Putrescin und Spermidin gering sind. Auch in Drosophila Schneider S2 Zellen und in adulten weiblichen Fliegen hat Spermin einen inhibitorischen, CK2-abhängigen Effekt auf die Aktivierung von Erk. Ausserdem konnte gezeigt werden, dass Putrescin und Spermidin in der Lage sind die Aktivierung von Erk, im Vergleich zu Zellen die nur mit Spermin behandelt wurden, zu erhöhen. Das spricht dafür, dass die Phosphorylierung von DRaf und die davon abhängige Aktivierung von Erk durch CK2 von der Menge und Relation der verschiedenen Polyamine zueinander abhängt. Die Ergebnisse dieser Arbeit lassen den Schluss zu, dass der Polyaminmetabolismus über CK2 mit dem MAPK-Signalweg verknüpft ist. Nachdem Polyamine durch Aminosäurekatabolismus enstehen, kann auf diese Weise der MAPK-Signalweg in Abhängigkeit der Verfügbarkeit zellulärer Aminosäuren reguliert werden. Vorversuche zeigten eine Beeinflussung von Proliferation und Apoptose durch CK2 und Polyamine. Weitere Untersuchungen sind aber nötig um spezifische Einflüsse von Polyaminen und CK2 auf zelluläre Prozesse wie Proliferation, Differenzierung und Apoptose aufzudecken. / Because of its high number and diversity of substrates, as well as its ability to cross-link signalling pathways, the heterotetrameric protein kinase CK2 has an exceptional position within kinases. CK2 influences proliferation, differentiation and apoptosis, processes in which also polyamines and the MAPK-signalling pathway are involved. A recent publication delineates binding of CK2 to the scaffold protein KSR and the enhancement of the MAPK-signalling pathway by phosphorylation of Raf-proteins in vertebrates. In my thesis I could show that CK2 also interacts with KSR in Drosophila and phosphorylates the only existing Raf protein in Drosophila (DRaf) in vitro. In contrast to the phosphorylation of human B-Raf- and C-Raf-proteins on serine 446 respectively serine 338 within the "negative charge regulatory region" (N-region), kinase reactions and mass spectrometric analyses led to the identification of serine 11 as phosphorylation site in DRaf, whereas a serine in the N-region, which corresponds to serine 446 of B-Raf, is not phosphorylated by CK2 in Drosophila. In cell culture experiments overexpression of DRaf and two DRaf-variants, in which serine 11 was substituted by alanine or aspartate (DRafS11A and DRafS11D), revealed the charge at amino acid position 11 to affect the function of DRaf, with a negative charge leading to phosphorylation and activation of the effector kinase Erk. Phosphorylation by CK2 is independent of second messengers, whereas it is modified by binding of polyamines. Intracellular polyamines mainly derive from cellular amino acid catabolism and modulate the phosphorylation of DRaf by CK2 in vitro with spermine being an efficient inhibitor of the reaction, whereas the effects of putrescine and spermidine are minor. In Drosophila Schneider S2 cells and adult flies spermine inhibits the activation of Erk in a CK2-dependent way. Furthermore administration of putrescine and spermidine in combination with spermine leads to enhanced Erk activation in cells compared to cells that are treated with spermine. These results suggest that phosphorylation of DRaf and the subsequent activation of Erk by CK2 are dependent on the amount and relative concentrations of polyamines. Altogether the results of this work demonstrate a role for CK2 in linking polyamine metabolism to the MAPK-signalling pathway. Since polyamines derive from amino acid catabolism, the MAPK-signalling pathway can be regulated dependent on the availability of cellular amino acids. Preliminary experiments point to CK2- and polyamine-dependent effects on proliferation and apoptosis. Further investigations are necessary to reveal specific effects of polyamines and CK2 on cellular processes like proliferation, differentiation and apoptosis.

A Proteína Transportadora de Poliaminas (PotD) é um antígeno importante para a virulência de Streptococcus pneumoniae in vivo, capaz de proteger camundongos imunizados contra infecção sistêmica, além de reduzir a colonização da nasofaringe dos animais. Porém, visando ampliar a cobertura vacinal, a combinação com outros antígenos da bactéria se faz necessária. Este trabalho teve como objetivo aprofundar o estudo sobre a resposta imune gerada contra a proteína PotD, sozinha ou em fusão com duas outras proteínas pneumocócicas: o derivado de Pneumolisina, PdT, e a proteína de superfície de pneumococo A (PspA). Para tanto, os genes potD, pdT e pspA foram clonados e expressos, sozinhos ou fusionados, gerando as proteínas híbridas rPotD-PdT e rPspA-PotD. As proteínas recombinantes e os híbridos foram utilizados na imunização subcutânea de camundongos BALB/c, gerando elevados níveis de anticorpos. O soro dos animais imunizados foi capaz de reconhecer e se ligar à superfície de diferentes isolados de pneumococos, e de ampliar a fagocitose da bactéria por células peritoneais murinas in vitro. Em todos os ensaios, os híbridos se mostraram mais eficazes do que as proteínas isoladas, induzindo anticorpos capazes de potencializar a fagocitose dos pneumococos. A resposta imune celular foi caracterizada pela produção de INF-γ, IL-2 e IL-17 pelos esplenócitos, e um aumento na produção de NO pelos fagócitos peritoneais dos animais imunizados. Apesar dos resultados promissores in vitro, a proteína rPotD-PdT não foi capaz de induzir proteção em nenhum dos modelos avaliados; em contraste, a fusão rPspAPotD foi capaz de proteger os camundongos contra sepse por dois isolados virulentos de pneumococo, além de reduzir a colonização na nasofaringe. Por fim, demonstramos que a adição das poliaminas transportadas por PotD, espermidina e putrescina, à cultura de pneumococos interfere na formação de biofilme in vitro. Cnsiderando o importante papel da formação de biofilmes na colonização, este resultado sugere um possível mecanismo de ação da PotD durante a colonização por pneumococo. Em conjunto, os resultados deste estudo sugerem que a utilização de uma formulação híbrida, rPspA-PotD, compreende uma estratégia vacinal promissora, capaz de proteger contra colonização e sepse pneumocócica, pela produção de anticorpos opsonizantes e ativação de citocinas protetoras, como IL-17. / Polyamine Transporter D (PotD) is an important antigen for Streptococcus pneumoniae virulence in vivo, protecting immunized mice against systemic infection and reducing the bacterial load in the nasopharynx of immunized animals. However, in order to extend vaccine coverage, the combination of PotD with other antigens of the bacterium is required. The present study aimed at expanding the investigation of the immune response generated against PotD alone or fused with two other pneumococcal proteins: the Pneumolysin derivative, PdT and Pneumococcal Surface Protein A (PspA). Therefore, the potD, pdt and pspA genes were cloned and expressed, either alone or in fusion, generating the hybrid proteins rPotD-PdT and rPspA-PotD. The recombinant proteins and hybrids were used for subcutaneous immunization of BALB/c mice, generating high levels of antibodies. Sera from immunized animals were able to recognize and bind onto the surface of different pneumococcal strains, and to enhance phagocytosis of the bacterium in vitro. In all tests, the hybrids were more effective than the isolated proteins. The cellular immune response was characterized by the production of INF-γ, IL-2 and IL-17 by splenocytes and increased production of NO by peritoneal cells of the immunized animals. Despite promising results in vitro, rPotD-PdT protein was not able to induce protection in any of the tested challenge models. In contrast, rPspA-PotD fusion was able to protect mice against sepsis with two virulent isolates of pneumococcus and led to reduction in bacterial loads in the nasopharynx of challenged animals. Finally, we demonstrate that the addition of exogenous polyamines, spermidine, and putrescine, in the pneumococcal culture interfered with biofilm formation in vitro. Considering the important role of biofilm formation for successful colonization, this result suggests a possible mechanism of action of PotD during colonization by pneumococcus. Taken together, the results suggest that the use of the hybrid rPspA-PotD comprises a promising vaccine strategy, able to protect against colonization and pneumococcal sepsis, through the production of opsonizing antibodies and activation of protective cytokines, such as IL-17.

<p>Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive disorder characterized by degeneration of motor neurons in the cortex, brainstem and spinal cord. The patients usually die within 3-5 years after onset. The full etiology of ALS is unknown and many hypotheses have been proposed to explain the neurodegeneration. However, basic mechanisms of cellular function such as transmethylation and polyamine metabolism have not been extensively studied in ALS. Transmethylation reactions are very important in the synthesis of substrates such as proteins, neurotransmitters, DNA and RNA. The polyamines, putrescine, spermidine and spermine, are involved in essential functions such as cellular growth, proliferation and differentiation.</p><p>An initial study in this thesis concerned the process of neuronal death (apoptosis) in ALS spinal cord. The results showed increased levels of an apoptosis-stimulating protein and increased levels of DNA fragmentation indicative of an apoptotic process in the tissue. A comparative study of MAT-enzyme activity in spinal cord from different mammalian species was undertaken to provide a background for future studies on transmethylation and neurodegeneration. Transmethylation reactions were found altered in erythrocytes from males with ALS but not in spinal cord from ALS patients as compared to controls. An adaptation of previously described polyamine assays was made for the study of polyamines in ALS spinal cord. The method was validated and applied for polyamine analysis in human materials of different characteristics. Determination of polyamines in control and ALS spinal cords showed no major differences. However, in female ALS patients, significantly increased spermidine and spermine levels were observed in ventral horn regions. These gender-related alterations in transmethylation and polyamine metabolism are of interest since there is a male preponderance for the disease.</p><p>The lack of major differences in polyamine levels between ALS and control spinal cord suggests a maintained regulation of polyamines at the end stage of this neurodegenerative disease.</p>

Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive disorder characterized by degeneration of motor neurons in the cortex, brainstem and spinal cord. The patients usually die within 3-5 years after onset. The full etiology of ALS is unknown and many hypotheses have been proposed to explain the neurodegeneration. However, basic mechanisms of cellular function such as transmethylation and polyamine metabolism have not been extensively studied in ALS. Transmethylation reactions are very important in the synthesis of substrates such as proteins, neurotransmitters, DNA and RNA. The polyamines, putrescine, spermidine and spermine, are involved in essential functions such as cellular growth, proliferation and differentiation. An initial study in this thesis concerned the process of neuronal death (apoptosis) in ALS spinal cord. The results showed increased levels of an apoptosis-stimulating protein and increased levels of DNA fragmentation indicative of an apoptotic process in the tissue. A comparative study of MAT-enzyme activity in spinal cord from different mammalian species was undertaken to provide a background for future studies on transmethylation and neurodegeneration. Transmethylation reactions were found altered in erythrocytes from males with ALS but not in spinal cord from ALS patients as compared to controls. An adaptation of previously described polyamine assays was made for the study of polyamines in ALS spinal cord. The method was validated and applied for polyamine analysis in human materials of different characteristics. Determination of polyamines in control and ALS spinal cords showed no major differences. However, in female ALS patients, significantly increased spermidine and spermine levels were observed in ventral horn regions. These gender-related alterations in transmethylation and polyamine metabolism are of interest since there is a male preponderance for the disease. The lack of major differences in polyamine levels between ALS and control spinal cord suggests a maintained regulation of polyamines at the end stage of this neurodegenerative disease.